Search

Search Results
Results 7401 - 7410 of 17271 for Active treatment
  • NIH awards $3.9 million grant to develop a non-opioid pain treatment
    News - 4 May 2026
    The National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health (NIH), has awarded a $3.9 million grant to a multi-institutional team led by scientists at...
  • Learn B.E. F.A.S.T. to recognize stroke signs and save lives
    News - 4 May 2026
    A stroke can change a life in an instant. In the minutes after symptoms begin, quick action can help protect the brain, reduce long-term disability and save a life, according to the American Stroke...
  • Elaprase
    Drug - 4 May 2026
    Consumer Medicine Information (CMI) about Elaprase intended for persons living in Australia.
  • Revestive
    Drug - 4 May 2026
    Consumer Medicine Information (CMI) about Revestive intended for persons living in Australia.
  • Keytruda
    Drug - 1 May 2026
    Consumer Medicine Information (CMI) about Keytruda intended for persons living in Australia.
  • New CAR T cell design boosts persistence and reduces toxicity
    News - 30 Apr 2026
    CAR T-cell therapy has transformed the treatment of hematologic malignancies, yet many patients do not achieve lasting benefit – often because the infused cells fail to expand or persist.
  • Tecentriq SC
    Drug - 30 Apr 2026
    Consumer Medicine Information (CMI) about Tecentriq SC intended for persons living in Australia.
  • Tecentriq
    Drug - 30 Apr 2026
    Consumer Medicine Information (CMI) about Tecentriq intended for persons living in Australia.
  • Lazcluze
    Drug - 30 Apr 2026
    Consumer Medicine Information (CMI) about Lazcluze intended for persons living in Australia.
  • Study reframes Hodgkin lymphoma as a cancer of failed cell development
    News - 24 Apr 2026
    For the first time, Weill Cornell Medicine researchers have demonstrated that Hodgkin lymphoma cancer cells from patient samples are immune cells stuck in an "identity crisis."

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback